FIELD: biotechnology.
SUBSTANCE: monoclonal antibodies and fragments thereof are described, that are cross-reactive with a plurality of influenza virus clades, including members of both Group 1 and Group 2.
EFFECT: antibodies are useful for control of epidemics and pandemics of influenza, and for provision of prophylactic or therapeutic protection against seasonal influenza.
16 cl, 8 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES USED PASSIVE VACCINATION AGAINST INFLUENZA | 2012 |
|
RU2668802C2 |
| ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA, AND COMPOSITIONS THEREOF, COMBINATIONS AND METHODS OF USING | 2015 |
|
RU2720282C1 |
| COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1 | 2013 |
|
RU2639551C2 |
| NEUTRALIZING BINDING MOLECULES DIRECTED AGAINST INFLUENZA VIRUS, AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2721706C2 |
| HIGH-AFFINITY HUMAN ANTIBODIES TO CYTOMEGALOVIRUS (CMV) gB PROTEIN | 2011 |
|
RU2613421C2 |
| ENHANCER ELEMENTS CPMV | 2015 |
|
RU2699982C2 |
| NEUTRALISING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF | 2014 |
|
RU2683498C2 |
| NEUTRALIZING ANTIBODIES AGAINST THE INFLUENZA A VIRUS AND WAYS OF THEIR APPLICATION | 2014 |
|
RU2803850C2 |
| IMMUNOGENIC EPITOPE OF INFLUENZA VIRUS | 2009 |
|
RU2546872C2 |
| NEUTRALISING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USING THEM | 2009 |
|
RU2553325C2 |
